Systemic mastocytosis with diffuse cutaneous involvement and haematological disease presenting in utero treated unsuccessfully with vincristine

Clinical and Experimental Dermatology

Volumn 33, Issue 1, 2008, Pages 36-39

  Angus, J ^a   Leach, I H ^a   Grant, J ^a   Ravenscroft, J C ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPHENIRAMINE; FRESH FROZEN PLASMA; PROTHROMBIN; VINCRISTINE;

ABDOMINAL DISTENSION; APGAR SCORE; ARTICLE; ASCITES; ASSISTED VENTILATION; BLOOD CLOTTING DISORDER; CARDIOMEGALY; CASE REPORT; CAUCASIAN; CESAREAN SECTION; CRYOPRECIPITATE; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; ENTERIC FEEDING; ERYTHEMA; FETUS DISTRESS; FETUS ECHOGRAPHY; FETUS MONITORING; GESTATIONAL AGE; HEMATOLOGIC DISEASE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HEPATOSPLENOMEGALY; HUMAN; INFANT; INTERNATIONAL NORMALIZED RATIO; INTUBATION; MALE; MAST CELL; MYELOPHTHISIC ANEMIA; PARTIAL THROMBOPLASTIN TIME; PRENATAL CARE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE; SYSTEMIC MASTOCYTOSIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; VESICULAR RASH;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASCITES; FATAL OUTCOME; FEMALE; FETAL DISTRESS; HEPATOMEGALY; HUMANS; INFANT, NEWBORN; MALE; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; PREGNANCY; PRENATAL CARE; SKIN DISEASES; SPLENOMEGALY; TREATMENT FAILURE; VINCRISTINE;

EID: 37349098789     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02555.x     Document Type: Article

References (14)

1. Valent P, Horny HP, Escribano L et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001 25 : 603 25.
2. Büttner C, Henz BM, Welker P et al. Identification of activating c-kit mutations in adults, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behaviour. J Invest Dermatol 1998 111 : 1227 31.
3. Yanagihori H, Oyama N, Nakamura K et al. C-kit mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation. J Mol Diagn 2005 7 : 252 7.
4. Kuint J, Bielorai B, Gilat D et al. C-kit activating mutation in a neonate with in-utero presentation of systemic mastocytosis associated with myeloproliferative disorder. Br J Haematol 1999 106 : 838 9.
5. Shah PY, Sharma V, Worobec A et al. Congenital bullous mastocytosis with myeloproliferative disorder and c-kit mutation. J Am Acad Dermatol 1998 39 : 119 21.
6. Potter MN, Kennedy CTC, Mott MJ. Congenital systemic mastocytosis. Br J Dermatol 1990 123 : 70 4.
7. Butterfield JH. Response of severe systemic mastocytosis to interferon alpha. Br J Dermatol 1998 138 : 489 95.
8. Droogendijk HJ, Kluin-Nelemans JC, van Doormaal JJ. Imatinib mesylate in the. treatment of systemic mastocytosis. A phase II trial. Cancer 2006 107 : 345 51.
9. Samorapoompichit P, Steiner M, Lucas T et al. Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugs. Leuk Lymphoma 2003 44 : 509 15.
10. Murphy M, Walsh D, Drumm B et al. Bullous mastocytosis: a fatal outcome. Paed Derm 1999 16 : 452 5.
11. Alison J. Skin mastocytosis presenting as neonatal bullous eruption. Australas J Dermatol 1967 9 : 83 85.
12. Yasuda T, Kukita A. A fatal case of purely cutanoeus form of diffuse mastocytosis (Mastocytose diffuse cutanee). Proceedings of the XIIth International Congress of Dermatology, DC. 1962 : 1558 61.
13. Davis RJ, Waisman M. Urticaria pigmentosa; report of a case with autopsy examination. Arch Dermatol 1959 79 : 649 50.
14. Ellis JM. Urticaria pigmentosa. Arch Pathol 1949 48 : 426 35.